These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11009265)

  • 1. Effects of cilostazol on angiographic restenosis after coronary stent placement.
    Park SW; Lee CW; Kim HS; Lee NH; Nah DY; Hong MK; Kim JJ; Park SJ
    Am J Cardiol; 2000 Sep; 86(5):499-503. PubMed ID: 11009265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine.
    Tanabe Y; Ito E; Nakagawa I; Suzuki K
    Int J Cardiol; 2001 May; 78(3):285-91. PubMed ID: 11376832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis.
    Kamishirado H; Inoue T; Mizoguchi K; Uchida T; Nakata T; Sakuma M; Takayanagi K; Morooka S
    Am Heart J; 2002 Aug; 144(2):303-8. PubMed ID: 12177649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RACTS: a prospective randomized antiplatelet trial of cilostazol versus ticlopidine in patients undergoing coronary stenting: long-term clinical and angiographic outcome.
    Ge J; Han Y; Jiang H; Sun B; Chen J; Zhang S; Du Z;
    J Cardiovasc Pharmacol; 2005 Aug; 46(2):162-6. PubMed ID: 16044027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cilostazol versus ticlopidine therapy after stent implantation.
    Park SW; Lee CW; Kim HS; Lee HJ; Park HK; Hong MK; Kim JJ; Park SJ
    Am J Cardiol; 1999 Sep; 84(5):511-4. PubMed ID: 10482146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
    Yoon Y; Shim WH; Lee DH; Pyun WB; Kim IJ; Jang Y; Cho SY
    Am J Cardiol; 1999 Dec; 84(12):1375-80. PubMed ID: 10606107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of cilostazol on long-term clinical outcomes after coronary stenting].
    Han YL; Wang SL; Li Y; Jing QM; Ma YY; Deng J; Yang GT; Yu HB; Ge JB
    Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):814-7. PubMed ID: 16316558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cilostazol on in-stent neointimal hyperplasia after coronary artery stenting: a quantative coronary angiography and volumetric intravascular ultrasound study.
    Min PK; Jung JH; Ko YG; Choi D; Jang Y; Shim WH
    Circ J; 2007 Nov; 71(11):1685-90. PubMed ID: 17965485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A paclitaxel-eluting stent for the prevention of coronary restenosis.
    Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS
    N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.
    Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N
    Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of cilostazol vs clopidogrel after drug-eluting stenting in diabetic patients--clilostazol for diabetic patients in drug-eluting stent (CIDES) trial.
    Ahn Y; Jeong MH; Jeong JW; Kim KH; Ahn TH; Kang WC; Park CG; Kim JH; Chae IH; Nam CW; Hur SH; Bae JH; Kim KY; Oh SK
    Circ J; 2008 Jan; 72(1):35-9. PubMed ID: 18159096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antiplatelet agents on subacute thrombosis and restenosis after successful coronary stenting: a randomized comparison of ticlopidine and cilostazol.
    Sekiguchi M; Hoshizaki H; Adachi H; Ohshima S; Taniguchi K; Kurabayashi M
    Circ J; 2004 Jul; 68(7):610-4. PubMed ID: 15226623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study.
    Iida O; Yokoi H; Soga Y; Inoue N; Suzuki K; Yokoi Y; Kawasaki D; Zen K; Urasawa K; Shintani Y; Miyamoto A; Hirano K; Miyashita Y; Tsuchiya T; Shinozaki N; Nakamura M; Isshiki T; Hamasaki T; Nanto S;
    Circulation; 2013 Jun; 127(23):2307-15. PubMed ID: 23652861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of aspirin versus cilostazol therapy after successful coronary stent implantation.
    Kunishima T; Musha H; Eto F; Iwasaki T; Nagashima J; Masui Y; So T; Nakamura T; Oohama N; Murayama M
    Clin Ther; 1997; 19(5):1058-66. PubMed ID: 9385493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cilostazol on late lumen loss and repeat revascularization after Palmaz-Schatz coronary stent implantation.
    Kozuma K; Hara K; Yamasaki M; Morino Y; Ayabe S; Kuroda Y; Tanabe K; Ikari Y; Tamura T
    Am Heart J; 2001 Jan; 141(1):124-30. PubMed ID: 11136497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial.
    Kastrati A; Schühlen H; Hausleiter J; Walter H; Zitzmann-Roth E; Hadamitzky M; Elezi S; Ulm K; Dirschinger J; Neumann FJ; Schömig A
    Circulation; 1997 Jul; 96(2):462-7. PubMed ID: 9244213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Debulking and stenting versus debulking only of coronary artery disease in patients treated with cilostazol (final results of ESPRIT).
    Tsuchikane E; Kobayashi T; Kobayashi T; Takeda Y; Otsuji S; Sakurai M; Awata N
    Am J Cardiol; 2002 Sep; 90(6):573-8. PubMed ID: 12231079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized Angiographic and Intravascular Ultrasound Comparison of Dual-Antiplatelet Therapy vs Triple-Antiplatelet Therapy to Reduce Neointimal Tissue Proliferation in Diabetic Patients.
    Zuliani Mauro MF; Mangione JA; Costa JR; Costa R; Piva E Mattos LA; Staico R; Feres F; Siqueira D; Sousa A; Abizaid A
    J Invasive Cardiol; 2017 Mar; 29(3):76-81. PubMed ID: 28255102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of post coronary stenting triple antiplatelet therapies on platelet functions].
    Han YL; Su QF; Li Y; Kang J; Yan CH; Wang SL
    Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):635-8. PubMed ID: 17074146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial.
    Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Kang SJ; Park SJ; Lee JH; Choi SW; Seong IW; Lee NH; Cho YH; Shin WY; Lee SJ; Lee SW; Hyon MS; Bang DW; Choi YJ; Kim HS; Lee BK; Lee K; Park HK; Park CB; Lee SG; Kim MK; Park KH; Park WJ;
    J Am Coll Cardiol; 2011 Mar; 57(11):1264-70. PubMed ID: 21392640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.